New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...

More tests are needed to confirm the cause of comedian Justin Moorhouse's son's death, a coroner has said. An inquest heard ...

As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...

Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy, the ...

RealTime Laboratories Inc., a medical and diagnostic laboratory specializing in mold and environmental toxin detection, today ...

In major relief for epilepsy patients, AIIMS New Delhi began providing free Therapeutic Drug Monitoring (TDM) from January 1 ...

Mark Cuban has a solution for the $38 trillion national debt: Fine health insurers for falling short Russia sends submarine ...

Producers are reminded to take steps to reduce the risk of annual ryegrass toxicity (ARGT) occurring in their livestock. Producers are reminded to ...

According to a new study, microplastics in the air in Xi'an city, China, more than tripled during the time period of their ...

Under the initiative, AIIMS will offer monitoring for commonly used anti-epileptic drugs such as phenobarbitone, ...